- Home
- PTLO vs SIGA Comparison
PTLO vs SIGA Comparison
Compare PTLO & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTLO | SIGA |
|---|---|---|
| Founded | 1963 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.4M | 401.0M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PTLO | SIGA |
|---|---|---|
| Price | $5.42 | $5.00 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $8.06 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 612.1K |
| Earning Date | 05-05-2026 | 03-10-2026 |
| Dividend Yield | N/A | ★ 12.15% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.27 | ★ 0.32 |
| Revenue | ★ $732,066,000.00 | N/A |
| Revenue This Year | $9.07 | $144.34 |
| Revenue Next Year | $6.31 | N/A |
| P/E Ratio | $20.35 | ★ $15.44 |
| Revenue Growth | ★ 3.03 | N/A |
| 52 Week Low | $4.41 | $4.81 |
| 52 Week High | $13.55 | $9.62 |
Technical Indicators
Market Signals| Indicator | PTLO | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 31.53 |
| Support Level | $5.34 | N/A |
| Resistance Level | $6.11 | $6.98 |
| Average True Range (ATR) | 0.26 | 0.27 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 51.42 | 10.98 |
Price Performance
Historical ComparisonAbout PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. The company owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, sides and soup, and others.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.